Dale Ando

Dale Ando is an experienced Advisory Committee Member with a strong background in the biotechnology industry, specializing in areas such as Vaccines, Oncology, Good Clinical Practice (GCP), Molecular Biology, and Biotechnology.

Having graduated from the University of Michigan, Dale holds a Bachelor of Science (BS) in Chemistry from Stanford University and a Doctor of Medicine (MD) from the University of Michigan.

Dale has held key positions in various prominent organizations including being the Founder of Gene Therapy and Genome Editing Consultant, Chief Medical Officer at Sangamo BioSciences, VP Clinical at Cell Genesys, Director at Viagene/Chiron Corporation, and has served as a Former Advisory Committee Industry Member at FDA Office of Cellular, Tissue and Gene Therapy Advisory Committee.